News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Molecular Targeting Technologies, Inc. Licenses Cell Targeting Technology from the Molecular Targeting Technologies, Inc.
March 1, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WEST CHESTER, Pa.--(BUSINESS WIRE)--Molecular Targeting Technologies, Inc., (MTTI) announced that it has obtained an exclusive license from the University of Notre Dame for novel sensing technology developed by Professor Bradley Smith.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
University of Notre Dame
MORE ON THIS TOPIC
Manufacturing
Radiopharma Sector Races To Secure Actinium-225 Supply as Pipelines Expand
February 17, 2026
·
4 min read
·
Nick Paul Taylor
Opinion
2026 Could Mark a Turning Point for American Innovation
February 16, 2026
·
4 min read
·
John Stanford
Earnings
Moderna’s FDA Challenges Stymie Breakeven Goal in ‘Fresh and Fluid’ Situation
February 13, 2026
·
5 min read
·
Annalee Armstrong
Gene therapy
Vertex, CRISPR Set Lofty Goal for Casgevy Gene Therapy as Patient Starts Ramp
February 13, 2026
·
3 min read
·
Dan Samorodnitsky